Blog
RSS FeedPosted by Michael Wonder on 21 May 2020
Canada grapples with drug price escalation
20 May 2020 - In July 2020 Canada will implement a series of reforms to help bring runaway drug prices under ...
Posted by Michael Wonder on 20 May 2020
Trump pushing for drug pricing action after Senate lunch
20 May 2020 - President Trump told Republican senators during a meeting on Tuesday that he still wants congressional action ...
Posted by Michael Wonder on 18 May 2020
International reference pricing gets thumbs down from ISPOR panel
18 May 2020 - International reference pricing, by which drug prices would be pegged to international standards, is under consideration ...
Posted by Michael Wonder on 18 May 2020
Beware of underpriced drugs for COVID-19 treatments
18 May 2020 - It has become painfully obvious that the only path back to normalcy involves either an effective ...
Posted by Michael Wonder on 17 May 2020
Less than a movie ticket or ‘impossible to overpay’? Experts name their price for remdesivir
15 May 2020 - Two weeks ago, the world learned that remdesivir, a treatment from Gilead Sciences, has a moderate ...
Posted by Michael Wonder on 14 May 2020
ICER’s cost model is not only wrong it’s also dangerous
11 May 2020 - There they go again. ...
Posted by Michael Wonder on 12 May 2020
Japan to set price of SMA drug Zolgensma at 167 million Yen
12 May 2020 - Japan's health ministry is planning to set the price of Novartis AG's spinal muscular atrophy drug ...
Posted by Michael Wonder on 11 May 2020
Pricing of COVID-19 treatments and coronavirus vaccines
11 May 2020 - At least 250 drugs and 95 vaccines are currently being investigated (mostly pre-clinical) in relation to ...
Posted by Michael Wonder on 08 May 2020
HyQvia gets a higher price
8 May 2020 - HyQvia 100 mg/mL solution for injection contains human immunoglobulin, which is an antibody used to strengthen ...
Posted by Michael Wonder on 07 May 2020
Generic drug maker admits to fixing prices for cholesterol medication
7 May 2020 - For conspiring to inflate drug prices, Apotex will pay $24 million and cooperate with the Justice Department’s ...
Posted by Michael Wonder on 06 May 2020
Jaguar Health says recent drug price hikes not tied to COVID-19 pandemic
6 May 2020 - Jaguar Health Inc’s recent price hikes on its anti-diarrhoeal drug, Mytesi, were not tied to the ...
Posted by Michael Wonder on 06 May 2020
Will Gilead price its coronavirus drug for public good or company profit?
7 May 2020 - Gilead faces a new dilemma in deciding how much it should profit from the only treatment so ...
Posted by Michael Wonder on 06 May 2020
Remdesivir helps coronavirus patients — but at what cost?
6 May 2020 - Drug maker Gilead is known for creating breakthrough drugs and selling them at a premium. ...
Posted by Michael Wonder on 05 May 2020
Teva and Celltrion Healthcare announce the launch of Truxima (rituximab-abbs) injection for rheumatoid arthritis, the only biosimilar to Rituxan (rituximab) available in the United States for this indication
4 May 2020 - Truxima is also now available for the treatment of granulomatosis with polyangiitis (Wegener’s granulomatosis) and microscopic polyangiitis. ...
Posted by Michael Wonder on 05 May 2020
Gilead's drug pricing in the crosshairs again in wake of OK to use remdesivir against COVID-19
4 May 2020 - Gilead plans to spend $1 billion on its COVID-19 drug remdesivir. Now some members of Congress ...